40 results
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... Bacterial Enteric Infections ... in HIV-AIDS Preventing ... Enteric #Bacterial #IDSA
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... in HIV-AIDS Preventing ... to 5 mg/kg/day IV ... Penicilliosis #IDSA
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... Preventing First ... HumanPapillomavirus #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... 800 mg) PO (or IV ... 800 mg) PO (or IV ... IsosporaBelli #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... for Preventing ... ) in HIV-AIDS Preventing ... Trypanosomiasis #IDSA ... opportunistic #infections
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... Mild infection: ... Severe infection ... erysipelas with no focus ... #cellulitis #idsa
Fine Ventricular Fibrillation on POCUS Echocardiogram (S4C) with Saline Contrast
POCUS may help you to spot fine
Fibrillation on POCUS ... Echocardiogram (S4C ... Saline Contrast POCUS ... just from rapid iv ... Echocardiogram #s4c
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention ... opportunistic #infections
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... #Prevention #Treatment ... opportunistic #infections
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... amphotericin B 3–5 mg/kg IV ... 0.7–1.0 mg/kg IV ... Coccidiodomycosis #IDSA ... #Prevention #Treatment